May 16-19, 2022, Washington, United States
Visit Merck at booth 351 to engage with our team and learn how we can help solve your challenges in cell and gene therapy manufacturing.
Don't miss our Technical Forum Presentation:
Monday, May 16 - 5:15pm
Bioprocess development using the VirusExpress® 293 AAV platform
Andi Ushijima, Scientist
View our Technical Posters:
Monday, May 16 – 5:30-6:30PM
Rapid Detection of Replication-Competent Adenovirus (RCA) in Adenoviral Vector Material
Author: Axel Fun, Principal Scientist (Virology)
Poster Board Number: M-307
Optimization and Characterization of the Chromatography Unit Operation for Lentivirus Production Platform
Author: Sana Afzal, Associate Scientist
Poster Board Number: M-283
Wednesday, May 18 – 5:30-6:30pm
Development and Scale-Up of a Transient AAV Production Process Using a Suspension-Adapted HEK293
Author: Andi Ushijma, Scientist
Poster Board Number: W-55
Improvement in Baseline Lentivirus Production using Design Of Experiment (DOE) Tool and Scale-up in Bench-Top Bioreactors
Author: Hiral Gami, Scientist
Poster Board Number: W-17
Venue: Walter E. Washington Convention Center
801 Mt Vernon Place NW
Washington, DC, 20001
United States
May 15-18, 2022
Walter E. Washington Convention Center
Booth: 351
Washington, United States